ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Morgan Dempsey Capital Management LLC

Morgan Dempsey Capital Management LLC decreased its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 2.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,332 shares of the medical instruments supplier’s stock after selling 293 shares during the period. Morgan Dempsey Capital Management LLC owned about 0.05% of ICU Medical worth $1,782,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Norges Bank purchased a new stake in shares of ICU Medical during the fourth quarter valued at approximately $18,127,000. Creative Planning raised its stake in shares of ICU Medical by 315.6% in the first quarter. Creative Planning now owns 665 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 505 shares during the period. Louisiana State Employees Retirement System raised its stake in shares of ICU Medical by 1.7% in the first quarter. Louisiana State Employees Retirement System now owns 6,000 shares of the medical instruments supplier’s stock valued at $916,000 after buying an additional 100 shares during the period. Rice Hall James & Associates LLC raised its stake in shares of ICU Medical by 2.7% in the first quarter. Rice Hall James & Associates LLC now owns 3,713 shares of the medical instruments supplier’s stock valued at $567,000 after buying an additional 98 shares during the period. Finally, State of Alaska Department of Revenue raised its stake in shares of ICU Medical by 2.5% in the first quarter. State of Alaska Department of Revenue now owns 1,640 shares of the medical instruments supplier’s stock valued at $250,000 after buying an additional 40 shares during the period. 77.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical, Inc. (NASDAQ:ICUI) traded down 0.41% during midday trading on Friday, reaching $169.30. The company had a trading volume of 73,333 shares. The company has a market capitalization of $3.36 billion, a P/E ratio of 67.80 and a beta of 0.37. The company’s 50 day moving average is $171.58 and its 200-day moving average is $159.92. ICU Medical, Inc. has a 52-week low of $120.15 and a 52-week high of $176.50.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing analysts’ consensus estimates of $0.58 by $0.06. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The firm had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. During the same period in the prior year, the business posted $1.15 EPS. The company’s revenue for the quarter was up 242.8% on a year-over-year basis. Equities analysts expect that ICU Medical, Inc. will post $4.11 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Rincon Hill News and is the sole property of of Rincon Hill News. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://rinconhillneighbors.org/2017/08/19/icu-medical-inc-nasdaqicui-shares-sold-by-morgan-dempsey-capital-management-llc-updated.html.

Several equities research analysts have recently commented on ICUI shares. Zacks Investment Research lowered ICU Medical from a “hold” rating to a “strong sell” rating in a research note on Wednesday, May 3rd. Roth Capital lowered ICU Medical from a “buy” rating to a “neutral” rating in a research note on Thursday, May 11th. They noted that the move was a valuation call. BidaskClub raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Saturday, June 17th. Sidoti lowered ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th. Finally, Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company’s stock. ICU Medical has an average rating of “Hold” and a consensus price target of $193.00.

In other ICU Medical news, CEO Vivek Jain sold 69,014 shares of the stock in a transaction that occurred on Friday, July 7th. The shares were sold at an average price of $171.10, for a total value of $11,808,295.40. Following the completion of the sale, the chief executive officer now owns 110,925 shares in the company, valued at approximately $18,979,267.50. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert S. Swinney sold 4,477 shares of the stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $175.00, for a total transaction of $783,475.00. Following the completion of the sale, the director now owns 23,293 shares of the company’s stock, valued at approximately $4,076,275. The disclosure for this sale can be found here. Insiders sold a total of 203,965 shares of company stock valued at $34,856,920 in the last ninety days. Company insiders own 15.90% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with our FREE daily email newsletter.

 

Latest News



Leave a Reply

 
© 2006-2017 Rincon Hill News.